You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
譽衡藥業(002437.SZ):產品已涵蓋骨骼肌肉等多個領域 核心產品市場份額在細分市場處於領先地位
格隆匯 05-22 16:23

格隆匯5月22日丨有投資者在投資者互動平台向譽衡藥業(002437.SZ)提問,“貴公司的產品相對於其他公司有哪些優勢呢?”

譽衡藥業回覆稱,公司自IPO以來,通過多年的產品引進、合作開發、投資併購等系列舉措,逐步實現了產品覆蓋領域廣、產品線豐富的產品優勢。目前,公司產品已涵蓋骨骼肌肉、心腦血管、維生素及礦物質補充劑、抗感染、抗腫瘤等多個領域。公司核心產品市場份額在細分市場處於領先地位。 關於公司具體產品信息,請您詳見2023年4月24日披露的《2022年年度報吿》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account